Clinical Trials Logo
  1. Home
  2. Pulmonary Artery Hypertension
  3. NCT06035861

Endothelial Cell Activation and Total Pulmonary Resistance in PAH

Pulmonary Artery Hypertension Clinical Trial

Official title:
Investigating the Relationship Between Endothelial Cell Activation and Total Pulmonary Resistance in Pulmonary Artery Hypertension (PAH)

Clinical Trial Summary

To determine whether changes in endothelial cell dysfunction are associated with changes in total pulmonary resistance in patients with pulmonary arterial hypertension

Clinical Trial Description

Patients with PAH will be exposed to XBD173. Markers of endothelial cell dysfunction and activation will be measured in the plasma, and changes in total pulmonary resistance will be meausured with an implantable monitor ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06035861
Study type Interventional
Source Imperial College London
Contact
Status Not yet recruiting
Phase N/A
Start date November 1, 2024
Completion date October 31, 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT05056532 - Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension
Active, not recruiting NCT06003244 - High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT) N/A
Active, not recruiting NCT06072417 - HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level) N/A
Recruiting NCT02966665 - : Vascular Function in Health and Disease Phase 1
Recruiting NCT00502398 - Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension? N/A
Completed NCT04456998 - GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) Phase 2
Recruiting NCT03138863 - Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) N/A
Recruiting NCT02102672 - Trimetazidine in Pulmonary Artery Hypertension Phase 2
Withdrawn NCT06122922 - Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN) Phase 2
Recruiting NCT03195543 - Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
Completed NCT04337671 - Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension N/A
Completed NCT03198910 - Retrospective Data Analysis of Data From the Zurich PH Registry
Completed NCT03979482 - Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH
Active, not recruiting NCT05996302 - HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level) N/A
Active, not recruiting NCT06084559 - HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT) N/A
Withdrawn NCT02684786 - A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension Phase 1
Not yet recruiting NCT06258850 - REstoration of VItamin D in Pulmonary Arterial Hypertension Phase 4
Completed NCT04094272 - Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection
Active, not recruiting NCT01763112 - Training With Whole Body Vibration Device in Patients With PAH N/A
Completed NCT01581086 - Vascular Subphenotypes of Lung Disease in HIV & COPD N/A